导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.18% | 769/1050 |
| 近一周 | -2.05% | 709/1104 |
| 近一月 | -5.74% | 837/1103 |
| 近一季 | 7.50% | 112/1092 |
| 近半年 | -4.84% | 614/1070 |
| 近一年 | -15.32% | 819/1018 |
| 近两年 | 39.98% | 593/926 |
| 近三年 | 8.30% | 609/834 |
| 成立以来 | 37.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.19% 830/1070 |
-7.07% 845/1101 |
- - |
- - |
| 2025 | 25.84% 570/1065 |
5.72% 359/1014 |
11.93% 68/1038 |
16.94% 696/1050 |
-9.05% 860/1065 |
| 2024 | -3.73% 669/1011 |
0.83% 274/960 |
-11.27% 897/983 |
11.19% 531/991 |
-3.22% 550/1011 |
| 2023 | -14.44% 500/952 |
2.05% 508/880 |
-12.05% 807/895 |
- 87/915 |
-4.67% 468/952 |
| 2022 | -25.21% 503/867 |
-12.27% 159/773 |
6.28% 449/806 |
-20.04% 752/845 |
0.30% 434/867 |
| 2021 | -9.92% 485/740 |
-4.35% 317/580 |
9.73% 362/659 |
-16.18% 631/704 |
2.38% 339/740 |
| 2020 | 31.74% 340/554 |
-9.03% 369/419 |
19.56% 293/466 |
8.92% 277/517 |
11.21% 327/554 |
| 2019 | 32.97% 273/410 |
20.79% 901/1149 |
-0.52% 413/1231 |
-1.86% 359/390 |
12.77% 96/410 |
| 2018 | -25.45% 155/349 |
- - |
- - |
- - |
-11.64% 504/1080 |
| 2017 | 39.29% 15/285 |
- - |
- - |
- - |
- - |
| 2016 | 7.18% 10/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 安信消费医药股票 VS. 东吴新产业精选股票A(580008) |